These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8387321)

  • 1. An unusual case of haematuria.
    Cassidy J; Kaye SB
    Eur J Cancer; 1993; 29A(6):906-7. PubMed ID: 8387321
    [No Abstract]   [Full Text] [Related]  

  • 2. Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
    Postmus PE; Smit EF; Berendsen HH; Haaxma-Reiche H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):17-23. PubMed ID: 1329219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary pure small cell carcinoma of the urinary bladder that responded to carboplatin plus etoposide: a case report and review of the literature.
    Kaya AO; Coskun U; Yildiz R; Gonul II; Karagulle K; Yaman E; Ozturk B
    J BUON; 2009; 14(4):703-6. PubMed ID: 20148466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
    Hosomi Y; Shibuya M
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1352-6. PubMed ID: 11681241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-finding studies with carboplatin, ifosfamide, etoposide, and mesna in non-small cell lung cancer.
    van Zandwijk N; ten Bokkel Huinink WW; Wanders J; Simonetti G; Dubbelman R; Franklin H; van Tinteren H; McVie JG
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):16-9. PubMed ID: 2154854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC).
    Preti P; Poggi G; Cuomo AM; Robustelli della Cuna FS; Zambelli A; Pavesi L
    J Chemother; 1998 Dec; 10(6):492-5. PubMed ID: 9876059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
    Postmus PE; Smit EF; Kirkpatrick A; Splinter TA
    Eur J Cancer; 1993; 29A(2):204-7. PubMed ID: 8380697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
    Lee HS; Lee YG; Koo DH; Oh S; Nam H; Song JU; Lim SY; Lim SY; Lee SS
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):933-7. PubMed ID: 26374553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.
    Bernstein ML; Whitehead VM; Devine S; Grier H; Kung F; Krischer J; Dreyer Z; Bell B; Land V; Buchanan GR
    Cancer; 1993 Sep; 72(5):1790-4. PubMed ID: 8348510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
    J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
    You B; Tranchand B; Girard P; Falandry C; Ribba B; Chabaud S; Souquet PJ; Court-Fortune I; Trillet-Lenoir V; Fournel C; Tod M; Freyer G
    Lung Cancer; 2008 Nov; 62(2):261-72. PubMed ID: 18442869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Small cell carcinoma of the urinary bladder: a case report and review of the Japanese literature].
    Okada Y; Kawakami S; Fukuda H; Nagahama K; Saito K; Ohtsuka Y; Kihara K; Morita T; Oshima H; Eishi Y; Kanno J
    Hinyokika Kiyo; 1997 Oct; 43(10):739-42. PubMed ID: 9395912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell carcinoma of the bladder: a case report and a literature review.
    Dalpiaz O; al Rabi N; Galfano A; Martignoni G; Ficarra V; Artibani W
    Arch Esp Urol; 2003 Mar; 56(2):197-202. PubMed ID: 12731451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of small cell lung cancer associated with fulminant hepatitis B].
    Watanabe Y; Tanaka H; Ogawa M; Tanaka T; Tanizawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Sep; 32(9):894-8. PubMed ID: 7799562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
    Evans WK; Stewart D; Logan D; Maroun J; Goss G; Shepherd FA; Latreille J; Warner E; Dahrouge S
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience.
    Pratt CB; Luo X; Fang L; Marina N; Avery L; Furman WL
    Med Pediatr Oncol; 1996 Sep; 27(3):145-8. PubMed ID: 8699990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary omental synovial sarcoma: a case with cytogenetic confirmation.
    Hemmings C; Fisher C
    Pathology; 2004 Apr; 36(2):208-11. PubMed ID: 15203764
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.
    Elias AD; Ayash LJ; Eder JP; Wheeler C; Deary J; Weissman L; Schryber S; Hunt M; Critchlow J; Schnipper L
    J Clin Oncol; 1991 Feb; 9(2):320-7. PubMed ID: 1846407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.